Skip to main content
Download PDF

Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry

Arthritis Research & Therapy volume 25, Article number: 210 (2023) Cite this article

The Original Article was published on 22 May 2023

Correction: Arthritis Res Ther 25, 86 (2023)

https://doi.org/10.1186/s13075-023-03045-3

Following publication of the original article [1], the authors reported an error found in the abstract section wherein the word “shorter” should be replaced by “longer”. The correct sentence should reads:

The factors associated with a higher probability of discontinuation on remission were shorter disease duration (OR: 0.95; 95% CI: 0.91–0.99), no concomitant use of classic DMARDs (OR: 0.56; 95% CI: 0.34–0.92), and longer usage of the previous bDMARD (before the decision to discontinue biological therapy) (OR: 1.01; 95% CI: 1.01–1.02); in contrast, smoking status (OR: 2.48; 95% CI: 1.21–5.08) was associated with a lower probability.

The original article [1] has been updated.

Reference

  1. Valero M, Sánchez-Piedra C, Freire M, et al. Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry. Arthritis Res Ther. 2023;25:86. https://doi.org/10.1186/s13075-023-03045-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Reumatologia, Hospital Universitario Ramon Y CajalInstituto Ramon Y Cajal de Investigacion Sanitaria (IRYCIS), Carretera de Colmenar Viejo Km: 9,100, 28034, Madrid, Spain

    Marta Valero

  2. Health Technology Assessment Agency of Carlos III Institute of Health (ISCIII), Madrid, Spain

    Carlos Sanchez-Piedra

  3. Department of Rheumatology, Complejo Hospitalario Universitario A Coruna, A Coruna, Spain

    Mercedes Freire

  4. Department of Rheumatology, Hospital Universitario de Burgos, Burgos, Spain

    Maria Colazo

  5. Department of Rheumatology, Hospital General de Granollers, Granollers, Barcelona, Spain

    Noemi Busquets

  6. Department of Rheumatology, Hospital Universitario Miguel Servet, Saragossa, Spain

    Erardo Merino-Ibarra

  7. Department of Rheumatology, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain

    Carlos Rodriguez-Lozano

  8. Department of Rheumatology, Hospital Universitario Regional de Malaga (Hospital Carlos Haya), Malaga, Spain

    Sara Manrique

  9. Department of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain

    Cristina Campos

  10. Research Unit of Spanish Society of Rheumatology, Madrid, Spain

    Fernando Sanchez-Alonso

  11. Department of Rheumatology, Hospital General Universitario Gregorio MaranonInstituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense de Madrid, Madrid, Spain

    Isabel Castrejon

Authors
  1. Marta Valero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Sanchez-Piedra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mercedes Freire
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Colazo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noemi Busquets
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Erardo Merino-Ibarra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Carlos Rodriguez-Lozano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sara Manrique
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Cristina Campos
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fernando Sanchez-Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Isabel Castrejon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta Valero.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valero, M., Sanchez-Piedra, C., Freire, M. et al. Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry. Arthritis Res Ther 25, 210 (2023). https://doi.org/10.1186/s13075-023-03194-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13075-023-03194-5

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us